• No se han encontrado resultados

Antihypertensive therapeutic potential of citronellal

N/A
N/A
Protected

Academic year: 2017

Share "Antihypertensive therapeutic potential of citronellal"

Copied!
1
0
0

Texto completo

(1)

767 ISSN 0326-2383

KEY WORDS: Bradycardia, Citronellal, Hypotension, Vasorelaxant effect.

* Author to whom correspondence should be addressed. E-mail:marcio@infonet.com.br

Latin American Journal of Pharmacy

(formerly

Acta Farmacéutica Bonaerense)

Lat. Am. J. Pharm.

31

(5): 767-71(2012)

Short communication Received: April 14, 2012 Revised version: June 15, 2012 Accepted: June 20, 2012

Antihypertensive Therapeutic Potential of Citronellal

Fernando C. ANDRADE, Marcelo M. MOTA, André S. BARRETO,

Damião P. SOUSA, Lucindo J. QUINTANS-JUNIOR & Márcio R.V. SANTOS *

Department of Physiology, Universidade Federal de Sergipe, São Cristóvão, SE, Brazil.

Referencias

Documento similar

Methods: The antihypertensive effect of fermented skim camel milk on thirty six male spontaneously hypertensive rats (SHR) was carried out for (short-term) and (long-term)

In controlled clinical trials the incidence of reports of heart failure with pioglitazone treatment was the same as in placebo, metformin and sulphonylurea treatment groups, but

Following a bout of activity with a CDAI of 262, treatment was initiated with GCAP with a fall of 92 points in CDAI after 5 weeks with corticosteroids re- duced to a half, but with

Thus, Se I 196.090 nm was selected as an atomic emission line affected by charge transfer reactions due to the presence of carbon, sulfur and phosphorus, whereas Mg

In Group B (5) the most frequently associated BPP was zolendronic acid in 40.3% of the patients, followed by tho- se who started their treatment with pamidronate and then

Children not allergic to penicillin Amoxicillin 50 mg/kg + clavulanic acid 6.25 mg/kg (maximum 2 g) oral route 1 hour before dental treatment.. Children not allergic to

The patient is diagnosed with urogenital tuberculosis and vertebral involvement L2-L3 (Pott disease), and he remains with tuberculostatic treatment (Isoniazid mg/..

The aim of this study was to identify which therapeutic, nutritional and microbiological factors in- fluence the development and severity of oral mucositis in head and neck